ResMed Inc Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: October 29, 2026 results vs estimates
ResMed Inc Forecast
ResMed Inc short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 21.3% a year, a typical one-standard-deviation range is 245.24–260.42 over a week, 237.27–268.39 over a month and 198.92–306.74 over a year. (Signals as of 1 Nov 2026.)
ResMed Inc Price Chart
ResMed Inc Factors
YoY −11.2%
YoY −9.8%
YoY +1.2%
YoY −12.1%
YoY −9.5%
YoY −7.4%
YoY +12.7%
YoY +13.1%
YoY −1.7%
YoY −25.6%
YoY −33.7%
YoY −8.2%
YoY −12.0%
YoY −43.8%
YoY −25.7%
YoY +14.3%
YoY −1.0%
ResMed Inc fundamentals: income statement, balance sheet & cash flow
ResMed Inc reported revenue of $5.65bn and net income of $1.52bn in FY2026, the year ended 30 June 2026 — revenue up 9.9% and net income up 8.8% on the prior year. Free cash flow was $1.65bn. These figures are as reported in the filings, not restated: 34 fiscal years and 137 quarters of history, back to June 1993. 173 FINRA short-interest settlements are published alongside them, back to June 2019.
| USD millions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 30 Jun 2026 | 30 Jun 2025 | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 |
| Revenue | 5,653.4 | 5,146.3 | 4,685.3 | 4,223.0 | 3,578.1 |
| Cost of revenue | 2,201.7 | 2,091.4 | 2,030.0 | 1,867.3 | 1,553.8 |
| Gross profit | 3,451.7 | 3,055.0 | 2,655.3 | 2,355.7 | 2,024.3 |
| Research & development | 378.3 | 331.3 | 307.5 | 287.6 | 253.6 |
| Operating income | 1,886.7 | 1,685.4 | 1,319.9 | 1,131.9 | 1,000.3 |
| EBITDA | 2,163.6 | 1,913.4 | 1,533.5 | 1,359.8 | 1,176.6 |
| Interest expense | 29.0 | 12.6 | 45.7 | 47.4 | 22.3 |
| Pre-tax income | 1,919.4 | 1,677.6 | 1,264.8 | 1,101.7 | 960.5 |
| Income tax | 396.1 | 276.8 | 243.8 | 204.1 | 181.0 |
| Net income | 1,523.3 | 1,400.7 | 1,021.0 | 897.6 | 779.4 |
Download ResMed Inc fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.RMD.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on ResMed Inc
Explore MacroFinance macro & markets research and analysis.
ResMed Inc Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to ResMed Inc; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow ResMed Inc’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About ResMed Inc (United States)
ResMed Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on ResMed Inc
Frequently asked questions
What is ResMed Inc?
What is the latest ResMed Inc price?
Is ResMed Inc in an uptrend?
How volatile is ResMed Inc?
What factors affect ResMed Inc?
Which trading strategies trade ResMed Inc?
How are ResMed Inc returns analysed?
Where can I download free ResMed Inc historical data?
Free ResMed Inc historical data (last 10 years)
Browse or instantly download the last 10 years of ResMed Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RMD.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 235.63 |
| 2026-11-19 | 236.88 |
| 2026-11-18 | 242.61 |
| 2026-11-17 | 237.85 |
| 2026-11-16 | 238.19 |
| 2026-11-13 | 239.53 |
| 2026-11-12 | 238.89 |
| 2026-11-11 | 237.87 |
| 2026-11-10 | 233.462 |
| 2026-11-09 | 235.088 |
About this stock
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.